Induction of sustained patency after clot-selective coronary thrombolysis with hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life

  • Carla J. Weinheimer
  • , Howard L. James
  • , Narender K. Kalyan
  • , James Wilhelm
  • , Shaw Guang Lee
  • , Paul P. Hung
  • , Burton E. Sobel
  • , Steven R. Bergmann

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Induction of sustained patency after clot-selective coronary thrombolysis with hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science